FDA Inspection
TAGI Pharma, Inc.FDA Inspection 1231414 - TAGI Pharma, Inc. - June 12, 2025
Record Details
This FDA Inspection record concerns TAGI Pharma, Inc., with an inspection on June 12, 2025, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · b816a923-9144-4171-bf81-6b385fb6f67a
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1231414
- FDA center
- Human Drugs
- Project area
- Bioresearch Monitoring
FDA Citations
1- 21 CFR 314.81(b)(2)Timely submission
Full citation text and observation details available on the Dashboard.
Other FDA inspections of TAGI Pharma, Inc.
1| Date | Classification | Office | Project area |
|---|---|---|---|
| December 13, 2017 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for TAGI Pharma, Inc.
- FDA Inspection 1036765 - 2017-12-13
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.